Bi-directional Tachycardia Drugs Market Trends

Growth Drivers

Increasing Prevalence of Cardiac Disorders Globally to Boost the Market Growth

Rising incidences of cardiovascular disorders across the world and related diseases such as arrhythmia, heart attacks and strokes is the key dynamic factor propelling the growth of bi-directional tachycardia drugs. According to World Health Organization (WHO), in 2016, an estimated 17.9 million people died from cardiovascular diseases (CVDs) which represents 31% of all deaths worldwide. Moreover, growing geriatric population diagnosed with heart diseases and changing lifestyles are other factors are anticipated to significantly expand the bi-directional tachycardia drugs market. 

Huge Investment in Healthcare R&D to Drive the Market Growth

The healthcare development all over the world is improving at a fast pace owing to the increasing number of cases of various diseases which results in a growing demand for better healthcare services, facilities and equipment at clinics and hospitals. The growing research activities for treatment methods at research laboratories further fuels the healthcare industry. On the back of such factors, the global bi-directional tachycardia drugs market is predicted to grow over the forecast period.

Challenges

High Cost and Side-Effects of Drugs to Hamper the Market Growth

Despite the improving healthcare infrastructure, there is a high cost involved in the drugs related to treatment of cardiovascular diseases. Further, there are major side effects associated with this drugs post medication. This is estimated to hinder the growth of bi-directional tachycardia drugs market in the future.